Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma. - Wikidata - awgldk - TriplyDB

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.

http://www.wikidata.org/entity/Q38906557

about

Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.Natural Killer Cells: Angels and Devils for Immunotherapy.The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors.PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO.

P2860

Q26751020-9876AFD7-5538-49A1-95A5-0195DEFABCB6 Q33691441-57C80F7F-BA7E-4908-8211-2F69C5B02592 Q33700795-5C777C4E-5A06-43F0-9B91-6E03CCF6AE39 Q35953824-C1D19320-AFFE-424C-A9E3-F92F82ADF47C Q37376346-1D635B28-7BAB-4C20-A5F0-A4A9852C7130 Q41661175-A3F60417-FDE6-4F61-975E-2CE63991604C Q47114749-18D52162-58F3-456A-847C-03F1356EE055 Q50445794-9363AFA9-8F78-4AC3-9972-1A322996B84C

P2860

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.

http://www.wikidata.org/entity/Q38906557

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Disialoganglioside-specific hu ...... drug-resistant neuroblastoma.

@en

type

label

Disialoganglioside-specific hu ...... drug-resistant neuroblastoma.

@en

prefLabel

Disialoganglioside-specific hu ...... drug-resistant neuroblastoma.

@en

P1433

Q38906557-A5842DED-2B64-43F3-A53B-7808C0C06CFF

P1476

Q38906557-DF06FFD4-1C35-45D8-BDBC-4BDCA730DD94

P2093

Q38906557-0B371540-467E-4392-89EA-31B4CBEAD46E

Q38906557-57C60CA5-EB5C-4CEE-B5E5-1384A2207ECF

Q38906557-A8994A1B-F759-409A-B214-DC50BA0EF070

Q38906557-CE83051B-2D57-4FE1-B767-EF220E672814

Q38906557-FA737365-9194-4837-8BD1-0D31582901EC

P2860

Q38906557-0116BED0-70CE-49AB-BDAB-B438AF8990B4

Q38906557-0144F4E2-2E0F-4D82-86BE-3EF3328E8899

Q38906557-024794D4-CD85-4253-8DCE-858939610FB2

Q38906557-19D10670-23CF-4875-ABB8-AF251C23D3C7

Q38906557-20BF3B5D-859F-421C-BE19-EB59B3957B2B

Q38906557-31D912BE-A890-46CD-8780-0BAF1C1C8316

Q38906557-31FBBA77-7CB3-4D92-9957-CFA2F4C4A193

Q38906557-323B9DC8-8742-405C-AD30-F3C4798E1EEE

Q38906557-3AF20D96-6633-4F7B-9429-A14C38E4B9CC

Q38906557-3B780B4F-5E12-43BC-91DB-CD974D1ADE27

P2888

Q38906557-300411FD-2D51-4E67-8B20-5B1C7C3C1BF3

P304

Q38906557-9DB5A663-9B8D-4DAF-8200-3399A42B0D04

P31

Q38906557-06EB413A-B2AD-40DE-9EB6-CAE6DEC7E0C6

P356

Q38906557-153822DE-8EB9-459C-A5C9-006943BECF14

P433

Q38906557-16959369-4644-42A2-B943-10DEE2F19510

P478

Q38906557-20B8C56B-B77E-4BD1-8D90-24A8D7FBDD34

P50

Q38906557-282CF5EF-45FC-42A2-9F58-D724F3A3D5EA

Q38906557-FCFA9220-4A09-4D01-BC67-9BA1F539F986

P577

Q38906557-45F5507E-E40D-45A8-A35C-5298E311E235

P5875

Q38906557-8BA6C152-AD8A-44E7-8956-FC2682F98E5E

P6179

Q38906557-51E5D506-D9A5-45BF-AA71-CE8C0BB90B52

P698

Q38906557-38CC0644-C561-4493-A622-202EAAD04DA3

P356

S00262-015-1669-5

P1433

Cancer Immunology, Immunotherapy

P1476

Disialoganglioside-specific hu ...... t drug-resistant neuroblastoma

@en

P2093

Anastasia Shibina

http://www.w3.org/2001/XMLSchema#string

Diana Seidel

http://www.w3.org/2001/XMLSchema#string

Nicole Huebener

http://www.w3.org/2001/XMLSchema#string

Nikolai Siebert

http://www.w3.org/2001/XMLSchema#string

Winfried S Wels

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Natural killer cell biology: an update and future directions

Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Biology of natural killer cells

Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Biology and clinical effects of natural killer cells in allogeneic transplantation.

Regulation of death receptor-mediated apoptosis pathways.

Chimeric antigen receptors for the retargeting of cytotoxic effector cells.

P2888

s00262-015-1669-5

P304

621-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-015-1669-5

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272841799

http://www.w3.org/2001/XMLSchema#string

P6179

1017423879

http://www.w3.org/2001/XMLSchema#string

P698

25711293

http://www.w3.org/2001/XMLSchema#string